1. Mechanisms of retinal ganglion cell death and neuroprotection

2. Glaucoma management

3. Stem cell therapy for retinal degeneration

4. Development of high-value intraocular implantable biomaterials

1. Pan Z, Li Z, Xie H, Huang Y, Xue CC, Wu X, Wong TY, Zhang C, Jonas JB, Wang YX. Reexamine the link between retinal layer thickness and cognitive function after correction of axial length: the Beijing Eye Study 2011. Graefes Arch Clin Exp Ophthalmol. 2025 Feb 26.

2. Zhang D, Yang Z, Li Z, Pan S, Zhang Y, Zhang K, Wu D, Kang L, Zhao C, Zhang C, Dong X. Human umbilical cord-derived mesenchymal stem/stromal cells via suprachoroidal injection: A novel approach for experimental uveitis treatment. Exp Eye Res. 2025 Apr 2;255:110373.

3. Zhang K, Wang Y, An Q, Ji H, Wu D, Li X, Suo L, Zhang C, Dong X. A Chemical Reprogramming Approach Efficiently Producing Human Retinal Pigment Epithelium Cells for Retinal Disease Therapies. Cell Prolif. 2024 Dec 12:e13785.

4. Dai J, Suo L, Xian H, Pan Z, Zhang C. Investigating the Impact of Sun/UV Protection and Ease of Skin Tanning on the Risk of Pseudoexfoliation Glaucoma: A Mendelian Randomization Study. Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):4.

5. Jin Y, Li Y, Song S, Ding Y, Dong Y, Lu Y, Liu D, Zhang C. DNA Supramolecular Hydrogel as a Biocompatible Artificial Vitreous Substitute. ADVANCED MATERIALS INTERFACES.2022 Feb 14;9(5):2101321.

6. Suo L, Dai W, Chen X, Qin X, Li G, Song S, Zhang D, Zhang C. Proteomics analysis of N-methyl-d-aspartate-induced cell death in retinal and optic nerves. J Proteomics. 2022 Feb 10;252:104427.

7. Xue CC, Cui J, Zhu XB, Xu J, Zhang C, Chen DN, Wang YX, Jonas JB. Serum Sodium Concentration and Increased Risk for Primary Epiretinal Membrane. Front Med (Lausanne). 2021 Dec 24;8:770362.

8. Chen X, Hong Y, Di H, Wu Q, Zhang D, Zhang C. Change of Retinal Vessel Density After Lowering Intraocular Pressure in Ocular Hypertension. Front Med (Lausanne). 2021 Dec 9;8:730327.

9. Wu Q, Xie M, Chen X, Zhang D, Chen X, Xu K, Hong Y, Zhang C. Temporal contrast adaptation in the analysis of visual function in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2022 Sep;260(9):2959-2970.

10. Lei L, Li S, Liu X, Zhang C. The clinical feature of myocilin Y437H mutation in a Chinese family with primary open-angle glaucoma. Br J Ophthalmol. 2019 Oct;103(10):1524-1529.

• Second Prize of Beijing Science and Technology Progress Award (First Contributor), 2022

• Achievement Award, Asia-Pacific Academy of Ophthalmology, 2015

• Henan Provincial Medical Science and Technology Progress Award (First Contributor), 2015

• IFOS/ICO Fellowship, 2003

• Postdoctoral Fellowship, Yale University, 2000

• Third Prize of Science and Technology Award from the Ministry of Education of China, 1996

• National Committee Member, Chinese Ophthalmological Society

• Committee Member, Chinese Glaucoma Society

• Standing Committee Member, Ophthalmology Branch, Chinese Preventive Medicine Association

• Chair, Chronic Ocular Disease Management, China Association of Gerontology and Health Society

• International Member, American Academy of Ophthalmology (AAO)

• Member, Association for Research in Vision and Ophthalmology (ARVO)

• Member, Asia-Pacific Glaucoma Society (APGS)

• Extraordinary Member, European Glaucoma Society (EGS)

• Member, International Glaucoma Surgery Society

• Executive Council Member, Beijing Medical Doctor Association, Ophthalmology Branch

• Standing Committee Member, Beijing Medical Association, Ophthalmology Branch

• Vice President, Second China “Belt and Road” Ophthalmology Alliance

• Standing Committee Member, Ophthalmology Branch, China International Exchange and Promotive Association for Medical and Health Care

• Committee Member, STAR Specialty Evaluation Committee